Location History:
- Beaverton, OR (US) (1989)
- Tucson, AZ (US) (1996 - 2013)
- Arvada, CO (US) (2002 - 2015)
Company Filing History:
10 out of 1,381 
2 out of 8,187 
1 out of 80 
Years Active: 1989-2015
Title: Richard A. Schmidt: Innovator in Neurotoxin Therapeutics
Introduction
Richard A. Schmidt is an accomplished inventor based in Arvada, Colorado, who has contributed significantly to the field of medical innovation. With a total of 18 patents to his name, Schmidt has focused his efforts on developing innovative therapies for neurological and urological conditions. His pioneering work in the application of botulinum toxin therapy showcases his commitment to advancing medical science.
Latest Patents
Among his most recent inventions are two notable patents that highlight his expertise in neurotoxin therapies. The first patent, titled "Use of Botulinum Toxin Therapy for Treatment of Urological Neurological Conditions," outlines methods for effectively treating various neurological-urological disorders through the administration of at least one neurotoxin. The second patent, "Use of Neurotoxin Therapy for Treatment of Urologic and Related Disorders," further explores similar therapeutic strategies that leverage neurotoxin applications to address neurological-urological conditions. These innovations not only demonstrate Schmidt's dedication to improving patient outcomes but also emphasize the transformative potential of neurotoxin therapy in modern medicine.
Career Highlights
Throughout his career, Schmidt has made significant strides in the medical research community. He has been affiliated with the University of Colorado, where he has contributed to advancing research and developing innovative therapeutic approaches. His extensive patent portfolio reflects his deep understanding of medical challenges and the creative solutions he proposes to address them.
Collaborations
Schmidt has had the opportunity to work alongside prominent colleagues, including Zdzislaw Salamon and Gordon Tollin. These collaborations have enriched his research experience and contributed to the innovative nature of his work, facilitating a cross-pollination of ideas that has further propelled his inventions.
Conclusion
Richard A. Schmidt is a noteworthy inventor whose work in neurotoxin therapy has significant implications for the treatment of neurological-urological conditions. His 18 patents exemplify his innovative spirit and dedication to enhancing medical therapies. Through his research and collaborations, Schmidt continues to pave the way for advancements in the medical field, offering hope for improved treatments in urological and neurological health.